Inessa Gendlina

Inessa Gendlina practices at Jack D Weiler Hospital in Bronx, New York.

Inessa Gendlina's NPI, 1851663660, was assigned on February 9, 2012. Inessa Gendlina graduated from University of Miami, Lm Miller School of Medicine in 2009. Inessa Gendlina holds New York license 264648.

Inessa Gendlina's primary practice is Jack D Weiler Hospital, at 1825 Eastchester Rd, Bronx, NY 10461 in Bronx County. The practice phone is (914) 377-4722.

Inessa Gendlina's primary practice is Jack D Weiler Hospital in Bronx, New York. Inessa Gendlina is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Inessa Gendlina to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Inessa Gendlina practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Inessa Gendlina's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Inessa Gendlina is licensed in New York.

CMS data shows 36 Medicare services from Inessa Gendlina across 2 procedure codes in 2024, for 46 Medicare patients. Medicare paid $3,499 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 46 Medicare patients who saw Inessa Gendlina in 2024. The largest group is 75 to 84, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 4.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Inessa Gendlina's median patient age at 59, with 40% women.

In 2024, Inessa Gendlina wrote 40 Medicare Part D claims. 73% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $6,682 in total drug cost. In 2023, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Inessa Gendlina for performance year 2024, reported as part of a group.

CMS Open Payments shows 3 general payments to Inessa Gendlina from 3 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 60% of the total. Alexion Pharmaceuticals, Inc. paid the most, $1,560.

Inessa Gendlina graduated from University of Miami, Lm Miller School of Medicine in 2009.